Sjogren’s syndrome Market Insights and Market Forecast

Sjogren’s syndrome Market Size and Share Analysis, Growth Opportunities, Current Treatment Practices, Emerging Therapies, Epidemiology Forecast The Sjogren’s syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Sjogren’s syndrome market dynamics. DelveInsight’s “Sjogren’s syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sjogren’s syndrome, historical and forecasted epidemiology as well as the Sjogren’s syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key facts of the Sjogren’s syndrome Market Report: ● The Sjogren’s syndrome market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

● The Sjögren's syndrome prevalence in the 7MM has affected around 400,000 and 3.1 million adults In the United Sates, Sjögren's syndrome prevalence affects around 1% of the total population The Sjögren's syndrome prevalence in the EU5 countries affects around 71.22 cases per 100,000 people Key Sjogren’s syndrome Companies: Gilead Sciences, Incyte Corporation, Novartis Pharmaceuticals, GlaxoSmithKline, Janssen Research & Development, LLC, and others Key Sjogren’s syndrome Therapies: Lanraplenib, Filgotinib, Tirabrutinib, Parsaclisib, VIB4920, CFZ533, Nipocalimab, and others ● ● ● ● Request a sample for the Sjogren’s syndrome Market Report Sjogren’s syndrome Overview The two most prevalent symptoms of Sjogren's syndrome, an immune system illness, are dry eyes and a dry mouth. The syndrome frequently coexists with other immune system diseases like lupus and rheumatoid arthritis. Sjogren's syndrome often affects your mucous membranes and moisture-secreting glands in your mouth and eyes first, which causes less saliva and tears to be produced. Although Sjogren's syndrome can strike at any age, most cases of the condition are detected in patients over the age of 40. In women, the illness is far more prevalent. The goal of Sjogren's syndrome treatment is to reduce symptoms. Sjogren’s syndrome Symptoms The Sjogren’s syndrome symptoms include - ● ● ● ● ● ● ● Dry Eyes Dry Mouth Joint Pain Swollen salivary glands Skin rashes Persistent dry cough Prolonged Fatigue Discover more about therapies set to grab major Sjogren’s syndrome market share @ Sjogren’s syndrome market forecast Sjogren’s syndrome Epidemiology Segmentation: The Sjogren’s syndrome market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into: ● ● ● ● Total Prevalence of Sjogren’s syndrome Prevalent Cases of Sjogren’s syndrome by severity Gender-specific Prevalence of Sjogren’s syndrome Diagnosed Cases of Episodic and Chronic Sjogren’s syndrome Sjogren’s syndrome Market

The dynamics of the Sjogren’s syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Filgotinib , Tirabrutinib, and others during the forecasted period 2019-2032. Download the report to understand which factors are driving Sjogren’s syndrome epidemiology trends @ Sjogren’s syndrome Epidemiological Insights Sjogren’s syndrome Therapies ● ● ● ● ● ● ● Lanraplenib Filgotinib Tirabrutinib Parsaclisib VIB4920 CFZ533 Nipocalimab Sjogren’s syndrome Key Companies ● ● ● ● ● Gilead Sciences Incyte Corporation Novartis Pharmaceuticals GlaxoSmithKline Janssen Research & Development, LLC Scope of the Sjogren’s syndrome Market Report ● ● Study Period: 2019–2032 Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan] Key Sjogren’s syndrome Companies: Gilead Sciences, Incyte Corporation, Novartis Pharmaceuticals, GlaxoSmithKline, Janssen Research & Development, LLC, and others Key Sjogren’s syndrome Therapies: Lanraplenib, Filgotinib, Tirabrutinib, Parsaclisib, VIB4920, CFZ533, Nipocalimab, and others Therapeutic Assessment: Sjogren’s syndrome current marketed and Sjogren’s syndrome emerging therapies Migraine Market Dynamics: Sjogren’s syndrome market drivers and barriers Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies Unmet Needs, KOL’s views, Analyst’s views, Sjogren’s syndrome Reimbursement ● ● ● ● ● ● Market Access and To know more about Sjogren’s syndrome treatment, visit @ Sjogren’s syndrome Medications Related Reports: Sjogren’s syndrome Pipeline "Sjogren’s syndrome Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Sjogren’s syndrome market. A

detailed picture of the Sjogren’s syndrome pipeline landscape is provided, which includes the disease overview and Sjogren’s syndrome treatment guidelines. Sjogren’s syndrome Epidemiology DelveInsight's 'Sjogren’s syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Sjogren’s syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology, and the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight

Sjogren’s syndrome Market Insights and Market Forecast

Sjogren’s syndrome Market Insights and Market Forecast

Presentation Transcript